Generic Versions of Suboxone Launching in the United States
An increasing number of pharmaceutical companies are launching generic versions of Suboxone in the United States since the court ruling that opened the market to competition, according to Bloomberg’s recent update on the topic. In February, after over two years of legal disputes regarding the potential infringement on Indivior’s Suboxone patent, the U.S. Supreme Court authorized Dr. Reddy’s Laboratories to resume selling its generic version of Suboxone.
Bloomberg quotes Brendan Saloner, an assistant professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, who speaks on the significance of this occurrence:
“It’s potentially a really big deal. (Suboxone Film has) a really important role in the overall strategy of combating the overdose crisis.”
Read the full article here.
Find doctors and treatment centers who administer Suboxone through our directory.